Key facts
- This page summarizes Christopher E. Kevane's Form 4 filing for UNIVERSAL TECHNICAL INSTITUTE INC (UTI).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Jan 2022, 17:37.
Christopher E. Kevane - 13 Jan 2022 Form 4 Insider Report for UNIVERSAL TECHNICAL INSTITUTE INC (UTI)
- Reporting relationship
- SVP Chief Legal Officer
- Issuer ticker
- UTI
- Reported as of
- 13 Jan 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 Jan 2022, 17:37:47 UTC
- Prior SEC filing
- 17 Dec 2021
- Next SEC filing
- 04 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher E. Kevane
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher E. Kevane filed Form 4 for UNIVERSAL TECHNICAL INSTITUTE INC (UTI) on 18 Jan 2022.
Change
- Previous filing in this sequence was filed on 17 Dec 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
UTI
transaction
Common Stock, $0.0001 par value
Options Exercise
- Transaction value
- $0
- Shares
- +858
- Change %
- +12%
- Price
- $0.000000
- Shares after
- 8,148
- Date
- 13 Jan 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
UTI
transaction
Derivative
Performance Units
Options Exercise
- Transaction value
- $0
- Shares
- -858
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 13 Jan 2022
- Ownership
- Direct
- Underlying class
- Common Stock, $0.0001 par value
- Underlying amount
- 858
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Each performance unit represents a contingent right to receive one share of the Company's Common Stock, $0.0001, 60% of which vested based on revenue and 40% of which vested based on income from operations for the fiscal year ended September 30, 2021, the sum of which was adjusted by the compound annual total shareholder return ("TSR") modifier. For purposes of determining the TSR, the change in the price of the Company's common stock was based upon the 30-trading day average closing stock price (i) ending on and including January 7, 2020, and (ii) ending on and including the last day of the Performance Period, or January 6, 2022. The number of shares delivered is equal to 8.6% performance achievement pursuant to the terms of the award and was approved by the Compensation Committee of the Board of Directors on January 13, 2022 per the terms of the award.